Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

China Pharma Wins FDA OK for Generic HIV Pill

publication date: Oct 10, 2007
This past summer, the FDA approved the application of Zhejiang Huahai Pharmaceutical Co. to produce a generic form of Viramune, an AIDS drug developed by Boehringer Ingelheim. Zhejiang Huahai must wait until May 2012 to being marketing the drug in the US, because Boehringer Ingelheim has patent protection for Viramune until then. The approval was the first time a China-based pharmaceutical company has received FDA approval to market finished pills in the US. More details...



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital